Delivery Order SPE2DB22D3016-SPE2DB24FARE2
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565614740 Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $2,166.87 and an ultimate completion date of August 29, 2024. AmerisourceBergen was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,072.73, is for the delivery of Ondansetron ODT 4 mg tablets with a performance period running through March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ondansetron ODT 4 mg tablets. The award has a ceiling value of $4,022.58 and a completion date of April 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is providing these pharmaceutical products in support of military treatment programs and facilities. This delivery order is part of a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $32,410.81 and a completion date of July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 4,563,925,268 units of Ondansetron ODT 4 mg tablets in 30-count packages, with a ceiling value of $8,952.84 and a period of performance through March 12, 2024. This delivery order falls under an...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The $3,361.80 contract has a June 26, 2025 completion date and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 8 mg tablets. The order has a completion date of February 6, 2024 and a potential value of $1,304.91. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) it holds with DLA to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The $3,065.00 fixed-price contract does not have a set-aside designation and has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the supply of Ondansetron ODT 4 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $1,711.16 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The award has a ceiling value of $3,374.31 and a period of performance through February 7, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FARE2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the provision of a pharmaceutical product, specifically Ondansetron ODT 4 mg tablets, to support military treatment programs and facilities. The delivery order has a ceiling value of $17,104.27 and an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order award is not associated with any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 3/28/24 |